q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

October 2015 Summary of the new Medications added to Medicare Part D Plan Formularies (Drug Lists) for January 2016

Category: Monthly Formulary Changes
Published: Dec, 15 2015 03:12:32
< Previous
Next >
The 2016 Medicare Part D plan formulary data (or drug lists) released in October 2015 include the addition of 167 new National Drug Codes (NDC) to the Medicare Part D program.  These NDCs represent 104 different drugs, many with multiple strengths.

Tolcapone, the generic for Tasmar was added to many 2016 Medicare Part D formularies, along with Naftifine HCl, the generic for Naftin; Entacapone, the generic for Comtan Entacapone; Aripiprazole, the generic for Abilify; and Alosetron HCl, the generic for Lotronex. 

The NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

There are many reasons for NDCs to be added to the Medicare Part D program, a summary is a follows:


Reason for NDC Addition Occurrences
New Delivery Form 13
New Delivery Form and Strength 5
New Drug 22
New Drug and Packaging 2
New Drug and Strength 27
New Drug, Delivery Form and Strength 2
New Drug, Manufacturer and Strength 12
New Manufacturer 7
New Manufacturer and Delivery Form 3
New Manufacturer and Strength 28
New Manufacturer, Strength and Delivery Form
 6
New Packaging
 2
New Strength 38
Total New NDCs 167

The following 167 manufacturer / drug / strength / packaging combinations (NDCs) were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Name below to go to our Q1Medicare.com DrugFinder to see the details of how this drug is handled by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
10631013331 ABSORICA 25 MG CAPSULE New Strength
10631013431 ABSORICA 35 MG CAPSULE New Strength
00054014225 ACARBOSE 100 MG TABLET New Strength
00517751003 ACETYLCYSTEINE 10% VIAL New Drug, Manufacturer and Strength
63323069210 ACETYLCYSTEINE 20% VIAL New Drug, Manufacturer and Strength
16714063201 ALENDRONATE SODIUM 35 MG TABLET New Manufacturer and Strength
00054029513 ALOSETRON HCL 0.5 MG TABLET [Lotronex] New Drug and Strength
00054029613 ALOSETRON HCL 1 MG TABLET [Lotronex] New Drug and Strength
42858040145 APTENSIO XR 10 MG CAPSULE New Drug and Strength
42858040245 APTENSIO XR 15 MG CAPSULE New Drug and Strength
42858040345 APTENSIO XR 20 MG CAPSULE New Drug and Strength
42858040445 APTENSIO XR 30 MG CAPSULE New Drug and Strength
42858040545 APTENSIO XR 40 MG CAPSULE New Drug and Strength
42858040645 APTENSIO XR 50 MG CAPSULE New Drug and Strength
42858040745 APTENSIO XR 60 MG CAPSULE New Drug and Strength
13811068130 ARIPIPRAZOLE 10 MG TABLET [Abilify] New Drug, Manufacturer and Strength
13811068230 ARIPIPRAZOLE 15 MG TABLET [Abilify] New Drug, Manufacturer and Strength
31722081930 ARIPIPRAZOLE 2 MG TABLET [Abilify] New Drug, Manufacturer and Strength
13811068310 ARIPIPRAZOLE 20 MG TABLET [Abilify] New Drug, Manufacturer and Strength
13811068410 ARIPIPRAZOLE 30 MG TABLET [Abilify] New Drug, Manufacturer and Strength
13811068030 ARIPIPRAZOLE 5 MG TABLET [Abilify] New Drug, Manufacturer and Strength
67457059200 ARIXTRA 2.5 MG SYRINGE New Manufacturer and Strength
59627000304 AVONEX PEN 30 MCG/0.5 ML KIT New Delivery Form
63323039810 Azithromycin i.v. 500 mg vial New Manufacturer
17478001202 BENZTROPINE 2 MG/2 ML VIAL New Manufacturer and Strength
00832108210 BENZTROPINE MESYLATE 2 MG TABLET New Manufacturer and Strength
63833082502 BERINERT 500 UNIT KIT New Drug
68084036501 Bethanechol 10 mg tablet New Drug, Manufacturer and Strength
00527133201 Bethanechol 5 mg tablet New Drug, Manufacturer and Strength
00173088210 BREO ELLIPTA 200-25 MCG INH New Strength
17478093101 Calcitriol 1 mcg/ml ampul New Manufacturer
00187205030 CARDIZEM LA 420 MG TABLET New Manufacturer and Strength
65224080202 CEDAX 90 MG/5 ML SUSPENSION New Strength
68180030320 CEFUROXIME AXETIL 500 MG TAB New Strength
00462039030 CLINDAMAX 1% GEL New Drug
00093731456 CLOPIDOGREL 75 MG TABLET [Plavix] New Manufacturer and Strength
00093308601 CLOZAPINE ODT 150 MG TABLET New Strength
00093308784 CLOZAPINE ODT 200 MG TABLET New Strength
55513080060 CORLANOR 5 MG TABLET New Drug and Strength
55513081060 CORLANOR 7.5 MG TABLET New Drug and Strength
00078063968 COSENTYX 150 MG/ML PEN INJECT New Drug
00469032014 CRESEMBA 186 MG CAPSULE New Drug, Delivery Form and Strength
00469042099 CRESEMBA 372 MG VIAL New Drug, Delivery Form and Strength
52054033095 DARAPRIM 25 MG TABLET New Drug
55566250000 DDAVP 0.01% NASAL SPRAY New Delivery Form and Strength
55566270000 DDAVP 0.2 MG TABLET New Strength
55566240000 DDAVP 10 MCG/0.1 ML SOLUTION New Delivery Form and Strength
00093555301 Dexmethylphenidate er 20 mg cp New Delivery Form and Strength
00409794109 Dextrose 5%-ns iv solution New Strength
00037686010 DIPENTUM 250 MG CAPSULE New Drug
00904640989 DONEPEZIL HCL 10 MG TABLET New Manufacturer
00904640889 DONEPEZIL HCL 5 MG TABLET New Manufacturer
63304061650 DOXYCYCLINE MONO 100 MG CAP New Manufacturer and Strength
23155013525 DOXYCYCLINE MONO 100 MG TABLET New Manufacturer, Strength and Delivery Form
68180065001 DOXYCYCLINE MONO 50 MG CAP New Manufacturer and Strength
23155013301 DOXYCYCLINE MONO 50 MG TABLET New Manufacturer, Strength and Delivery Form
62064001160 EGRIFTA 2 MG VIAL New Drug
62935022305 ELIGARD 22.5 MG SYRINGE New Strength
58406044501 ENBREL 50 MG/ML SURECLICK SYR New Delivery Form
00378908001 ENTACAPONE 200 MG TABLET [Comtan Entacapone] New Drug
54505010201 Epinephrine 0.3 mg auto-inject New Strength
60505004101 ETODOLAC 400 MG TABLET New Manufacturer
54092025702 FOSRENOL 1,000 MG POWDER PACK New Delivery Form
54092025602 FOSRENOL 750 MG POWDER PACKET New Delivery Form
00409610210 Furosemide 40 mg/4 ml vial New Manufacturer and Delivery Form
00781323434 Glatopa 20 mg/ml syringe New Drug
00002751601 HUMALOG 100 UNITS/ML CARTRIDGE New Delivery Form
00002879901 HUMALOG 100 UNITS/ML KWIKPEN New Strength
00002771227 HUMALOG 200 UNITS/ML KWIKPEN New Strength
00002880301 HUMULIN 70-30 PEN New Delivery Form
00002880501 HUMULIN N 100 UNITS/ML PEN New Delivery Form
63323061401 HYDRALAZINE 20 MG/ML VIAL New Manufacturer and Strength
68462035205 HYDROXYZINE HCL 10 MG TABLET New Manufacturer
00093506210 HYDROXYZINE HCL 50 MG TABLET New Manufacturer and Delivery Form
13533061802 HYPERRAB S-D 150 UNITS/ML VIAL New Drug and Packaging
13533061810 HYPERRAB S-D 150 UNITS/ML VIAL New Drug and Packaging
27437029806 IRENKA DR 40 MG CAPSULE New Drug
00093532828 JUNEL FE 24 TABLET New Manufacturer and Strength
76431013001 JUXTAPID 30 MG CAPSULE New Strength
76431014001 JUXTAPID 40 MG CAPSULE New Strength
76431016001 JUXTAPID 60 MG CAPSULE New Strength
10337090544 KERYDIN 5% TOPICAL SOLUTION New Drug
63323016212 Ketorolac Tromethamine Inj 30 MG/ML New Manufacturer and Strength
00074305846 K-tab er 8 meq tablet New Strength
68135048210 KUVAN 500 MG POWDER PACKET New Delivery Form and Strength
51991075910 LETROZOLE 2.5 MG TABLET New Drug
00378728590 Levonor-eth Estrad 0.15-0.03-0.01 New Strength
00093824465 linezolid 600 mg tablet [Zyvox] New Manufacturer and Delivery Form
69238125208 LOPREEZA 0.5 MG-0.1 MG TABLET New Drug and Strength
69238125108 LOPREEZA 1 MG-0.5 MG TABLET New Drug and Strength
00185007201 LOVASTATIN 20 MG TABLET New Manufacturer and Strength
51672529404 MALATHION 0.5% LOTION New Drug
00603437216 MEFENAMIC ACID 250 MG CAPSULE New Drug
62559019016 METOCLOPRAMIDE 5 MG/5 ML SOLN New Strength
43386058130 METOCLOPRAMIDE HCL ODT 5 MG TB New Manufacturer
40085020190 NAFTIFINE HCL 1% CREAM [Naftin] New Drug
52544016528 NECON 7-7-7-28 TABLET New Strength
55513053010 NEUPOGEN 300 MCG/ML VIAL New Strength
51079058501 Nitrofurantoin mcr 100 mg cap New Manufacturer and Strength
68462065629 NORETHIN-ETH ESTRAD 0.5-2.5 New Manufacturer and Strength
68462065790 NORETHIN-ETH ESTRAD 1 MG-5 MCG New Manufacturer and Strength
00169330312 NOVOLOG 100 UNIT/ML CARTRIDGE New Delivery Form
00264446000 NUTRILIPID 20% IV FAT EMULSION New Delivery Form
68982085001 OCTAGAM 10% VIAL New Drug, Manufacturer and Strength
67467084305 OCTAGAM 5% VIAL New Drug, Manufacturer and Strength
00004036530 PEGASYS PROCLICK 180 MCG/0.5 New Strength
00085435501 PEGINTRON 120 MCG KIT New Strength
00228280111 PILOCARPINE HCL 5 MG TABLET New Manufacturer, Strength and Delivery Form
00409790609 Kcl 40 meq in d5w solution New Strength
59310058020 PROAIR RESPICLICK INHAL POWDER New Delivery Form
00228278011 PROPRANOLOL ER 120 MG CAPSULE New Manufacturer, Strength and Delivery Form
00228278111 PROPRANOLOL ER 160 MG CAPSULE New Manufacturer, Strength and Delivery Form
00245008510 PROPRANOLOL ER 80 MG CAPSULE New Manufacturer, Strength and Delivery Form
40076051145 Prudoxin 5% cream New Drug
00185434601 QUINIDINE SULFATE 200 MG TAB New Manufacturer and Strength
59137051004 RASUVO 10 MG/0.2 ML AUTOINJ New Drug and Strength
59137051504 RASUVO 12.5 MG/0.25 ML AUTOINJ New Drug and Strength
59137052004 RASUVO 15 MG/0.3 ML AUTOINJ New Drug and Strength
59137052504 RASUVO 17.5 MG/0.35 ML AUTOINJ New Drug and Strength
59137053004 RASUVO 20 MG/0.4 ML AUTOINJ New Drug and Strength
59137053504 RASUVO 22.5 MG/0.45 ML AUTOINJ New Drug and Strength
59137054004 RASUVO 25 MG/0.5 ML AUTOINJ New Drug and Strength
59137054504 RASUVO 27.5 MG/0.55 ML AUTOINJ New Drug and Strength
59137055004 RASUVO 30 MG/0.6 ML AUTOINJ New Drug and Strength
59137050504 RASUVO 7.5 MG/0.15 ML AUTOINJ New Drug and Strength
44087332201 REBIF REBIDOSE 22 MCG/0.5 ML New Delivery Form
44087334401 REBIF REBIDOSE 44 MCG/0.5 ML New Delivery Form
44087018801 REBIF REBIDOSE TITRATION PACK New Delivery Form
00187514045 RETIN-A MICRO 0.1% GEL New Strength
00591210930 RISEDRONATE SODIUM 30 MG TABLET [Actonel] New Manufacturer and Strength
00093309844 RISEDRONATE SODIUM 35 MG TABLET [Actonel] New Manufacturer and Strength
00591207539 RISEDRONATE SODIUM 35 MG TABLET [Actonel] New Manufacturer and Strength
00591210230 RISEDRONATE SODIUM 5 MG TABLET [Actonel] New Manufacturer and Strength
00093550944 RISEDRONATE SODIUM DR 35 MG TABLET [Actonel] New Manufacturer and Strength
68382015406 RISPERIDONE 0.5 MG ODT New Strength
68382015606 RISPERIDONE 2 MG ODT New Strength
00078065815 RITALIN LA 60 MG CAPSULE New Strength
00456240260 SAPHRIS 2.5 MG TAB SL BLK CHRY New Strength
55150016613 Sildenafil 10 mg/12.5 ml vial New Manufacturer and Strength
57894007102 SIMPONI 100 MG/ML PEN INJECTOR New Packaging
57894007002 SIMPONI 50 MG/0.5 ML PEN INJEC New Packaging
00597015561 STIOLTO RESPIMAT INHAL SPRAY New Drug
00187552560 TARGRETIN 1% GEL New Delivery Form and Strength
62756001740 Testosterone cyp 100 mg/ml New Manufacturer and Strength
62756001640 Testosterone cyp 200 mg/ml New Manufacturer and Strength
42211020129 TIVORBEX 20 MG CAPSULE New Drug and Strength
42211020229 TIVORBEX 40 MG CAPSULE New Drug and Strength
49884025409 Tolcapone 100 MG TABLET [Tasmar] New Drug
65862016401 TRANDOLAPRIL 1 MG TABLET New Manufacturer and Strength
65862016501 TRANDOLAPRIL 2 MG TABLET New Manufacturer and Strength
65862016601 TRANDOLAPRIL 4 MG TABLET New Manufacturer and Strength
66530025645 TRETINOIN 0.01% GEL New Manufacturer and Strength
16781037635 TRETIN-X 0.0375% CREAM New Drug
59762371803 TRIAZOLAM 0.25 MG TABLET New Strength
58809082016 VANATOL LQ ORAL SOLUTION New Drug
53270012601 VARIZIG 125 UNIT/1.2 ML VIAL New Drug
69413055840 VECAMYL 2.5 MG TABLET New Drug
31722033110 WARFARIN SODIUM 4 MG TABLET New Strength
00486077116 Zamicet 10-325 mg/15 ml soln New Drug
43376031060 ZOHYDRO ER 10 MG CAPSULE New Strength
43376031560 ZOHYDRO ER 15 MG CAPSULE New Strength
43376032060 ZOHYDRO ER 20 MG CAPSULE New Strength
43376033060 ZOHYDRO ER 30 MG CAPSULE New Strength
43376034060 ZOHYDRO ER 40 MG CAPSULE New Strength
43376035060 ZOHYDRO ER 50 MG CAPSULE New Strength
55566190101 ZOMACTON 10 MG VIAL New Drug and Strength
55566180101 ZOMACTON 5 MG VIAL New Drug and Strength


You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at Q1Medicare.com/FormularyBrowser or compare how any medication is covered on all Medicare plans in your service area using our Q1Medicare.com/DrugFinder.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.